Busulfan Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Oct 24, 2025 · last update Oct 24, 2025
Manufacturers: Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08) | Mylan Institutional, a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted Oct 24, 2025 Updated Oct 24, 2025 Discontinued Oct 24, 2025 |